American non-financial companies have already issued over €40 billion in so-called Reverse Yankee bonds this year, marking a record surge in U.S. Firms raising capital in the European debt market, according to Bank of America data reported by multiple sources.
The rush to issue euro-denominated debt comes as the differential between U.S. And Eurozone policy rates has widened, making borrowing in euros more attractive for American companies. The European Central Bank (ECB) noted in a recent report that the share of these bonds denominated in euro relative to those in U.S. Dollars has historically been correlated with expectations about policy rates. The OIS differential widened in 2024, contributing to the increased appeal of euro issuance.
Reverse Yankee bonds are issued by U.S. Firms in a foreign currency – in this case, the euro. The Financial Times reported that strong demand from European debt investors has fueled the trend. Issuers include companies in sectors ranging from pharmaceuticals and consumer goods to fintech, with the market becoming a primary source of corporate bond sales in Europe.
Borrowing costs are influenced not only by risk-free rate differentials but as well by credit spreads and the cost of hedging foreign exchange risk. The ECB’s analysis indicates that differences in investor bases and perceived risks between the U.S. And Eurozone markets can affect the premiums paid by U.S. Companies. Firms issuing debt in a foreign currency face exchange rate risk, which can be mitigated through FX market or basis swap market hedging, particularly for those with assets and operations in the corresponding currency.
As of May 9th, the volume of Reverse Yankee deals had already surpassed previous records, with five borrowers poised to make this the busiest start to the year ever, according to the Financial Times. The trend reflects a strategic shift by U.S. Companies to capitalize on favorable conditions in the European debt market.
